← Back to headlines

Takeover fever rampant in biotechnology industry
More biotech firms are likely to change hands this year than ever before. Many pharmaceutical groups urgently need new products. Roche and Novartis are also on a shopping spree.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



